Literature DB >> 32225139

Use of Alu Element Containing Minigenes to Analyze Circular RNAs.

Justin R Welden1, Anna Pawluchin1, Jacob van Doorn1, Stefan Stamm2.   

Abstract

In addition to linear mRNAs, many eukaryotic genes generate circular RNAs. Most circular RNAs are generated by joining a 5' splice site with an upstream 3' splice site within a pre-mRNA, a process called back-splicing. This circularization is likely aided by secondary structures in the pre-mRNA that bring the splice sites into close proximity. In human genes, Alu elements are thought to promote these secondary RNA structures, as Alu elements are abundant and exhibit base complementarities with each other when present in opposite directions in the pre-mRNA. Here, we describe the generation and analysis of large, Alu element containing reporter genes that form circular RNAs. Through optimization of cloning protocols, reporter genes with up to 20 kb insert length can be generated. Their analysis in co-transfection experiments allows the identification of regulatory factors. Thus, this method can identify RNA sequences and cellular components involved in circular RNA formation.

Entities:  

Year:  2020        PMID: 32225139     DOI: 10.3791/59760

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  3 in total

Review 1.  The design and synthesis of circular RNAs.

Authors:  Prisca Obi; Y Grace Chen
Journal:  Methods       Date:  2021-03-02       Impact factor: 3.608

2.  Circular versus linear RNA topology: different modes of RNA-RNA interactions in vitro and in human cells.

Authors:  Sonja Petkovic; Sarah Graff; Nina Feller; Julia Berghaus; Vanessa-Patricia Ruppert; Jasmin Dülfer; Georg Sczakiel
Journal:  RNA Biol       Date:  2021-11-28       Impact factor: 4.652

3.  The Regulation of circRNA RNF13/miRNA-1224-5p Axis Promotes the Malignant Evolution in Acute Myeloid Leukemia.

Authors:  Rong Zhang; Yingchun Li; Hongtao Wang; Ke Zhu; Guojun Zhang
Journal:  Biomed Res Int       Date:  2020-10-06       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.